Literature DB >> 26392705

An updated review of Terminalia catappa.

Arumugam Vijaya Anand1, Natarajan Divya2, Pannerselvam Punniya Kotti3.   

Abstract

Terminalia catappa Linn. is known for its nutritional fruit and possesses medicinal benefits as well. This is a comprehensive review of the phytoconstituents and pharmacological benefits. T. catappa has been recognized for its medicinally essential phytoconstituents, such as phenol, flavonoid, and carotenoid. Numerous pharmacological investigations have confirmed this plant's ability to exhibit antimicrobial, anti-inflammatory, antidiabetic, antioxidant, hepatoprotective, and anticancer activities, all of which support its traditional uses.

Entities:  

Keywords:  Anticancer; Terminalia catappa; antidiabetic; antioxidant; hepatoprotective

Year:  2015        PMID: 26392705     DOI: 10.4103/0973-7847.162103

Source DB:  PubMed          Journal:  Pharmacogn Rev        ISSN: 0973-6581


  33 in total

1.  Effective protection of Terminalia catappa L. leaves from damage induced by carbon tetrachloride in liver mitochondria.

Authors:  Xinhui Tang; Jing Gao; Yanping Wang; Yi-Mei Fan; Li-Zhi Xu; Xiao-Ning Zhao; Qiang Xu; Zhong Ming Qian
Journal:  J Nutr Biochem       Date:  2005-08-10       Impact factor: 6.048

2.  Folk medicine Terminalia catappa and its major tannin component, punicalagin, are effective against bleomycin-induced genotoxicity in Chinese hamster ovary cells.

Authors:  P S Chen; J H Li; T Y Liu; T C Lin
Journal:  Cancer Lett       Date:  2000-05-01       Impact factor: 8.679

3.  Modifying effects of Terminalia catappa on azoxymethane-induced colon carcinogenesis in male F344 rats.

Authors:  T Morioka; M Suzui; V Nabandith; M Inamine; Y Aniya; T Nakayama; T Ichiba; N Yoshimi
Journal:  Eur J Cancer Prev       Date:  2005-04       Impact factor: 2.497

4.  Tannin-rich fraction from Terminalia catappa inhibits quorum sensing (QS) in Chromobacterium violaceum and the QS-controlled biofilm maturation and LasA staphylolytic activity in Pseudomonas aeruginosa.

Authors:  Joemar C Taganna; Jusal P Quanico; Rose Marie G Perono; Evangeline C Amor; Windell L Rivera
Journal:  J Ethnopharmacol       Date:  2011-02-01       Impact factor: 4.360

5.  Hepatoprotective activity of Terminalia catappa L. leaves and its two triterpenoids.

Authors:  Jing Gao; Xinhui Tang; Huan Dou; Yimei Fan; Xiaoning Zhao; Qiang Xu
Journal:  J Pharm Pharmacol       Date:  2004-11       Impact factor: 3.765

6.  Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin.

Authors:  S Kinoshita; Y Inoue; S Nakama; T Ichiba; Y Aniya
Journal:  Phytomedicine       Date:  2007-02-12       Impact factor: 5.340

7.  Beneficial lipid-lowering effects of pink guava puree in high fat diet induced-obese rats.

Authors:  M N Norazmir; M Y Ayub
Journal:  Malays J Nutr       Date:  2010-04-15

8.  Mechanisms of hepatoprotection of Terminalia catappa L. extract on D-Galactosamine-induced liver damage.

Authors:  Xin-Hui Tang; Ling Gao; Jing Gao; Yi-Mei Fan; Li-Zhi Xu; Xiao-Ning Zhao; Qiang Xu
Journal:  Am J Chin Med       Date:  2004       Impact factor: 4.667

9.  Antimutagenicity of supercritical CO2 extracts of Terminalia catappa leaves and cytotoxicity of the extracts to human hepatoma cells.

Authors:  Ting-Fu Ko; Yih-Ming Weng; Shwu-Bin Lin; Robin Y-Y Chiou
Journal:  J Agric Food Chem       Date:  2003-06-04       Impact factor: 5.279

10.  Characterization and Quantification of Compounds in the Hydroalcoholic Extract of the Leaves from Terminalia catappa Linn. (Combretaceae) and Their Mutagenic Activity.

Authors:  Francisco José Mininel; Carlos Sérgio Leonardo Junior; Lívia Greghi Espanha; Flávia Aparecida Resende; Eliana Aparecida Varanda; Clarice Queico Fujimura Leite; Wagner Vilegas; Lourdes Campaner Dos Santos
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-09       Impact factor: 2.629

View more
  7 in total

1.  Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp.

Authors:  Analucia G Terças; Andrea de Souza Monteiro; Eduardo B Moffa; Julliana R A Dos Santos; Eduardo M de Sousa; Anna R B Pinto; Paola C da Silva Costa; Antonio C R Borges; Luce M B Torres; Allan K D Barros Filho; Elizabeth S Fernandes; Cristina de Andrade Monteiro
Journal:  Front Microbiol       Date:  2017-04-10       Impact factor: 5.640

Review 2.  The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer.

Authors:  Yi-Hsuan Hsiao; Chiao-Wen Lin; Po-Hui Wang; Min-Chien Hsin; Shun-Fa Yang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

3.  Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats.

Authors:  Franklyn Nonso Iheagwam; Olawumi Toyin Iheagwam; Michael Kemjika Onuoha; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

4.  Terminalia catappa leaf extracts inhibited metastasis of A2058 and A375 melanoma cells via downregulating p-Src and β-catenin pathway in vitro.

Authors:  Chin-Kuo Chang; Shu-Chen Chu; Jing-Yang Huang; Pei-Ni Chen; Yih-Shou Hsieh
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

5.  Effects of Terminalia catappa Linn. Extract on Candida albicans biofilms developed on denture acrylic resin discs.

Authors:  Letícia Machado-Gonçalves; Adriano Tavares-Santos; Fábio Santos-Costa; Rafael Soares-Diniz; Livia Câmara-de Carvalho-Galvão; Eduardo Martins-de Sousa; Marco-Aurélio Beninni-Paschoal
Journal:  J Clin Exp Dent       Date:  2018-07-01

6.  Leaf Damage by Phytophagous Beetles alters Terminalia catappa Green and Senesced Leaf Chemistry.

Authors:  Thomas E Marler
Journal:  Int J Insect Sci       Date:  2018-08-30

7.  GC-MS Analysis and Inhibitory Evaluation of Terminalia catappa Leaf Extracts on Major Enzymes Linked to Diabetes.

Authors:  Franklyn Nonso Iheagwam; Emmanuel Nsedu Israel; Kazeem Oyindamola Kayode; Opeyemi Christianah De Campos; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-05       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.